BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12226549)

  • 1. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells.
    Morikawa S; Takabe W; Mataki C; Kanke T; Itoh T; Wada Y; Izumi A; Saito Y; Hamakubo T; Kodama T
    J Atheroscler Thromb; 2002; 9(4):178-83. PubMed ID: 12226549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells.
    Lopez S; Peiretti F; Bonardo B; Juhan-Vague I; Nalbone G
    Atherosclerosis; 2000 Oct; 152(2):359-66. PubMed ID: 10998463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
    J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
    Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA
    Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
    Schönbeck U; Gerdes N; Varo N; Reynolds RS; Horton DB; Bavendiek U; Robbie L; Ganz P; Kinlay S; Libby P
    Circulation; 2002 Dec; 106(23):2888-93. PubMed ID: 12460867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins.
    Igarashi J; Miyoshi M; Hashimoto T; Kubota Y; Kosaka H
    Br J Pharmacol; 2007 Feb; 150(4):470-9. PubMed ID: 17220911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH; Gebauer M; Güldenzoph B; Hecker M
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical promoter region for statin-induced human endothelial nitric oxide synthase (eNOS) transcription in EA.hy926 cells.
    Mashimo Y; Ishikawa T; Numakura M; Kinoshita M; Teramoto T
    J Atheroscler Thromb; 2013; 20(4):321-9. PubMed ID: 23258079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner.
    Torrens C; Kelsall CJ; Hopkins LA; Anthony FW; Curzen NP; Hanson MA
    Hypertension; 2009 Apr; 53(4):661-7. PubMed ID: 19221211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
    Teupser D; Bruegel M; Stein O; Stein Y; Thiery J
    Biochem Biophys Res Commun; 2001 Dec; 289(4):838-44. PubMed ID: 11735122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide.
    Dayoub JC; Ortiz F; López LC; Venegas C; Del Pino-Zumaquero A; Roda O; Sánchez-Montesinos I; Acuña-Castroviejo D; Escames G
    J Pineal Res; 2011 Oct; 51(3):324-30. PubMed ID: 21585521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global analysis of RNA expression profile in human vascular cells treated with statins.
    Morikawa S; Takabe W; Mataki C; Wada Y; Izumi A; Saito Y; Hamakubo T; Kodama T
    J Atheroscler Thromb; 2004; 11(2):62-72. PubMed ID: 15153665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of LOX-1 by statins may relate to upregulation of eNOS.
    Mehta JL; Li DY; Chen HJ; Joseph J; Romeo F
    Biochem Biophys Res Commun; 2001 Dec; 289(4):857-61. PubMed ID: 11735125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
    Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
    Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.
    Dichtl W; Dulak J; Frick M; Alber HF; Schwarzacher SP; Ares MP; Nilsson J; Pachinger O; Weidinger F
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):58-63. PubMed ID: 12524225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study.
    Lin LY; Huang CC; Chen JS; Wu TC; Leu HB; Huang PH; Chang TT; Lin SJ; Chen JW
    Cardiovasc Diabetol; 2014 Jul; 13():111. PubMed ID: 25027585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors.
    Rashid M; Tawara S; Fukumoto Y; Seto M; Yano K; Shimokawa H
    Circ J; 2009 Feb; 73(2):361-70. PubMed ID: 19060417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins.
    Morikawa S; Murakami T; Yamazaki H; Izumi A; Saito Y; Hamakubo T; Kodama T
    J Atheroscler Thromb; 2005; 12(3):121-31. PubMed ID: 16020911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells.
    Morikawa S; Umetani M; Nakagawa S; Yamazaki H; Suganami H; Inoue K; Kitahara M; Hamakubo T; Kodama T; Saito Y
    J Atheroscler Thromb; 2000; 7(3):138-44. PubMed ID: 11480454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase.
    Ohira M; Endo K; Saiki A; Miyashita Y; Terai K; Murano T; Watanabe F; Tatsuno I; Shirai K
    Metabolism; 2012 Oct; 61(10):1452-60. PubMed ID: 22520230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.